undamentalytics Newsletter
Sign in

Corteva, Inc. (CTVA) stock

Add to watchlist

Add holding +

NYSE: CTVA NYSE Fertilizers & Agricultural Chemicals Next results ~November 11, 2026

C+ Fundamentals grade

Corteva, Inc. is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger).

Price vs value

Under review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger). We'll show the comparison once resolved.

Corteva, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

Value diary

Our note on each quarter Corteva files

Where Corteva stands after its latest Filing

Revenue for the twelve months was $17.8bn, up 3.7% on a year earlier, slower than 6.3% a quarter earlier. Free-cash-flow margin fell to 3.5% from 15.1% a year earlier. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 1 of our 1 financial-health checks.

Our model value for Corteva is under review, so past values are not shown until it is resolved.

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 11, 2026 (estimated)

Corteva, Inc.'s trailing-twelve-month revenue grew 3.7% year on year, with a free-cash-flow margin of 3.5%. Where it stands out: gross margin of 49.5% ranks 1 of 11 fertilizers & agricultural chemicals companies we cover. Where it lags: days sales outstanding of 120 days ranks 6 of 7 fertilizers & agricultural chemicals companies we cover.

Our discounted-cash-flow model values the business at ~$32 per share in the base case (~$23–$45 across growth scenarios) — model values under stated assumptions, not a price target.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 75.8% while net income fell 28.0%: a 48pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Shrinking share count. Diluted shares fell 1.9% in a year, so each share owns more of the business.

Things to watch

  • Growth easing. The growth rate is 2.6 points lower than a quarter earlier.
  • Weak cash conversion. Free cash flow was 62% of net income over the last 12 months.
  • Below peers: days sales outstanding. Days sales outstanding of 120 days ranks 6 of 7 fertilizers & agricultural chemicals companies we cover (median 75 days).
  • Short interest rising. Shares sold short rose 87% in a month to 6.6% of tradable shares.

Latest results: FY2026 Q2

Filed July 31, 2026
Revenue
$6.38bn, down 1.2% on a year earlier
Share reaction
-13.0% in the first session after the results on July 30, 2026, against +2.4% for the S&P 500
Guidance given
operating EBITDA $4.1bn to $4.3bn (full-year 2026); operating EPS $3.6 to $3.8 (full-year 2026)
Next report
November 11, 2026; average EPS estimate $0.10

Corteva's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+2.4%
  • 1 week-0.3%
  • 1 month0.0%
  • This year+19.3%
  • 1 year+30.5%
  • 5 years+87.0%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$17.8B
Net margin
5.7%
EPS (TTM, diluted)
$1.50

Growth

Revenue growth
+3.7%
Change in growth rate
−2.6 pts
Share count change
−1.9%

Cash

Free cash flow (TTM)
$629M
FCF margin
3.5%

Earnings

Last results
July 30, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Dividend
  2. Announcement
  3. Leadership
  4. Announcement
  5. Deal
  6. Announcement
  7. Announcement
  8. Announcement
  9. Announcement
  10. Announcement
  11. Announcement
  12. Announcement
  13. Announcement
  14. Announcement
  15. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Corteva, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: held for review: analysts' forecasts describe a different business from the one in the latest filings (spin-off, disposal or merger).

Our value per share comes from a discounted-cash-flow model of Corteva, Inc.'s free cash flow after stock-based pay ( $1.5B, FY2026 Q2 TTM, with after-tax interest added back): growth for five years as below (the first two years from forecasts, guidance and the company's record), fading to 2.5%, discounted at 8.5%, then cash added and debt and other claims subtracted. These are model values under stated assumptions, not price targets or recommendations.

Valuation multiples over time Market data may be delayed

At fiscal year end 2019202020212022202320242025Now
Share price$4.09$5.46$6.75$8.47$6.99$8.40$9.99$11.92
Market value$3.1bn$4.1bn$5.0bn$6.1bn$5.0bn$5.8bn$6.8bn$8.0bn
+ Net debt (− = net cash)−$1.6bn−$2.4bn−$3.3bn−$1.9bn−$155m−$403m−$1.9bn$2.5bn
Enterprise value$1.4bn$1.7bn$1.7bn$4.3bn$4.8bn$5.4bn$4.9bn$10.6bn
Multiples
Price / sales 0.2x0.3x0.3x0.4x0.3x0.3x0.4x0.5x
Price / earnings —6.0x2.8x5.4x6.8x6.4x6.2x8.0x
Price / free cash flow —2.6x2.3x23.0x4.2x3.8x2.4x12.8x
EV / EBITDA ————————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

53 /100

Moderate moat

How hard Corteva's competitive advantage looks for rivals to wear away, judged from 8 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 10 / 20

    Cash operating profit has been a median 8.2% of total assets over 8 years.

  • Pricing power 13 / 20

    Gross margin has been a median 41.2%, moving by 3.8 percentage points (standard deviation) across 8 years.

  • Durability 0 / 20

    Net margin has been a median 5.5%; its worst year was -44.5%.

  • Cash conversion 11 / 20

    Free cash flow was positive in 6 of 8 years, at a median 6.1% of revenue.

  • Discipline 20 / 20

    The diluted share count fell 9.8% over five years; stock-based pay has been a median 0.8% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 11, 2026, after the close. Analysts expect revenue of $1.8bn and EPS of $0.10 (range $0.00 to $0.18) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $1.07 — $7.8bn —
Next $1.12 +5% $8.1bn +3%

Management guidance

Earnings release, July 30, 2026
  • Operating EPS full-year 2026 $3.60 to $3.80 Non-GAAP Raised
    “Operating EPS1 is expected to be $3.60 to $3.80 per share, growth of 11% at the mid-point.” source
  • Operating EBITDA full-year 2026 $4.1bn to $4.3bn Non-GAAP Raised
    “As a result of these market dynamics and coupled with our strong first half execution, the Company increased full-year 2026 guidance3 with Operating EBITDA1 expected to be $4.1 billion to $4.3 billion, growth of 9% at the mid-point.” source
  • net pre-tax restructuring charges · Crop Protection 2026 $140m to $150m
    “The Company expects to record approximately $140 million to $150 million net pre-tax restructuring charges during 2026 for these activities.” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Our model doesn't use the consensus here: consensus revenue is 0.31x the latest quarter's run rate while reported revenue fell 1% a year: a different business (spin-off, disposal or merger) - not used.

Analyst recommendations

13 analysts, Oct 2026
Buy1185%
Hold215%
Sell00%

Monthly trend

  1. Oct 202638213

Counts of recommendations published by analysts covering Corteva, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
6.6%
of tradable shares
Days to cover
1.38
at average volume
Short interest, 1 month
+87%
to October 15, 2026
Held by institutions
92%
of shares
Held by insiders
0.2%
of shares

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months +30.5%

$9.13 on October 31, 2025 to $11.92

ThenNowEffect
Revenue (last 12 months) $17.2bn $17.8bn +3.7%
Net margin 8.2% 5.7% −30.5%
P/E multiple 4.5x 8.0x +77.7%
Share count 688m 675m +2.0%

Biggest factor: p/e multiple.

Last 3 years +63.3%

$7.30 on November 3, 2023 to $11.92

ThenNowEffect
Revenue (last 12 months) $17.5bn $17.8bn +1.6%
Net margin 5.3% 5.7% +7.6%
P/E multiple 5.7x 8.0x +40.5%
Share count 718m 675m +6.3%

Biggest factor: p/e multiple.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
CTVA+24%+26%−18%+20%+19%+19%
Industry peers (median)+72%+16%−16%−8%−7%+12%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
CTVA67%75%42%67%50%55%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
CTVA−18%−19%−32%−12%−21%−22%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since May 24, 2019: 35% from December 2, 2022 to November 10, 2023. Getting back needed a 53% gain, reached on January 30, 2025, 447 days after the low.

Price behaviour

52-week range
$9.22 – $14.45
From 52-week high
−17.5%
vs 50-day average
−4.9%
vs 200-day average
−1.2%
Volatility (1 year)
31%
Beta vs S&P 500
0.04

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±5.9%
After a week
6 up, 6 down
typical move ±6.8%
After a month
7 up, 5 down
typical move ±6.9%
Results releasedNext dayS&P 500 next day5 days21 days
July 30, 2026 −13.0% +2.4% −15.1% −7.3%
May 5, 2026 +0.1% +2.2% +1.1% −5.0%
February 3, 2026 +2.6% −1.3% +1.4% +4.9%
November 4, 2025 +2.6% −0.8% +5.9% +7.1%
October 1, 2025 −6.1% +0.5% −6.7% −8.8%
August 6, 2025 −1.7% +0.7% 0.0% +0.2%
May 7, 2025 +7.1% +1.1% +8.2% +15.0%
February 5, 2025 −5.1% +0.8% −5.5% −7.6%
November 6, 2024 −5.0% +3.3% −6.6% −3.4%
July 31, 2024 −4.6% +0.2% −8.6% +2.6%
May 1, 2024 +5.3% +0.6% +5.0% +3.3%
January 31, 2024 +18.0% −0.3% +18.0% +17.4%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Corteva, Inc. in five measures

Fundamentals grade C+
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Corteva, Inc.
$16.5B $17B $17.5B $18B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $17.3B Revenue (TTM), FY23 Q4: $17.2B Revenue (TTM), FY24 Q1: $16.8B Revenue (TTM), FY24 Q2: $16.9B Revenue (TTM), FY24 Q3: $16.6B Revenue (TTM), FY24 Q4: $16.9B Revenue (TTM), FY25 Q1: $16.8B Revenue (TTM), FY25 Q2: $17.2B Revenue (TTM), FY25 Q3: $17.5B Revenue (TTM), FY25 Q4: $17.4B Revenue (TTM), FY26 Q1: $17.9B Revenue (TTM), FY26 Q2: $17.8B $17.8B

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $17.3B
FY23 Q4 $17.2B
FY24 Q1 $16.8B
FY24 Q2 $16.9B
FY24 Q3 $16.6B
FY24 Q4 $16.9B
FY25 Q1 $16.8B
FY25 Q2 $17.2B
FY25 Q3 $17.5B
FY25 Q4 $17.4B
FY26 Q1 $17.9B
FY26 Q2 $17.8B
Revenue growth, TTM YoY Corteva, Inc.
-10% -5% 0% 5% 10% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: 1.4% Revenue growth, TTM YoY, FY23 Q4: -1.3% Revenue growth, TTM YoY, FY24 Q1: -5.1% Revenue growth, TTM YoY, FY24 Q2: -3.6% Revenue growth, TTM YoY, FY24 Q3: -4.1% Revenue growth, TTM YoY, FY24 Q4: -1.8% Revenue growth, TTM YoY, FY25 Q1: -0.0% Revenue growth, TTM YoY, FY25 Q2: 1.6% Revenue growth, TTM YoY, FY25 Q3: 5.0% Revenue growth, TTM YoY, FY25 Q4: 2.9% Revenue growth, TTM YoY, FY26 Q1: 6.3% Revenue growth, TTM YoY, FY26 Q2: 3.7% 3.7%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 1.4%
FY23 Q4 -1.3%
FY24 Q1 -5.1%
FY24 Q2 -3.6%
FY24 Q3 -4.1%
FY24 Q4 -1.8%
FY25 Q1 -0.0%
FY25 Q2 1.6%
FY25 Q3 5.0%
FY25 Q4 2.9%
FY26 Q1 6.3%
FY26 Q2 3.7%
FCF margin (TTM) Corteva, Inc.
-5% 0% 5% 10% 15% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -0.8% FCF margin (TTM), FY23 Q4: 6.8% FCF margin (TTM), FY24 Q1: 11.2% FCF margin (TTM), FY24 Q2: 8.9% FCF margin (TTM), FY24 Q3: 10.5% FCF margin (TTM), FY24 Q4: 9.2% FCF margin (TTM), FY25 Q1: 12.5% FCF margin (TTM), FY25 Q2: 15.1% FCF margin (TTM), FY25 Q3: 15.2% FCF margin (TTM), FY25 Q4: 16.2% FCF margin (TTM), FY26 Q1: 11.4% FCF margin (TTM), FY26 Q2: 3.5% 3.5%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -0.8%
FY23 Q4 6.8%
FY24 Q1 11.2%
FY24 Q2 8.9%
FY24 Q3 10.5%
FY24 Q4 9.2%
FY25 Q1 12.5%
FY25 Q2 15.1%
FY25 Q3 15.2%
FY25 Q4 16.2%
FY26 Q1 11.4%
FY26 Q2 3.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ billions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2018 Dec 2018 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 14.3 13.8 14.2 15.7 17.5 17.2 16.9 17.4 17.8
Gross profit 4.3 5.3 5.7 6.4 7.0 7.3 7.4 8.2 8.8
Net income −5.1 −1.0 0.7 1.8 1.1 0.7 0.9 1.1 1.0
Diluted EPS −$6.76 −$1.28 $0.91 $2.37 $1.58 $1.03 $1.30 $1.60 $1.50
Growth (year on year)
Revenue — −3.1% +2.7% +10.1% +11.5% −1.3% −1.8% +2.9% +3.7%
Net income — — — +158.3% −34.8% −35.9% +23.4% +20.6% −28.0%
Diluted EPS — — — +160.4% −33.3% −34.8% +26.2% +23.1% −26.6%
Margins
Gross margin 30.4% 38.1% 40.2% 41.1% 40.2% 42.4% 43.6% 47.3% 49.5%
Net margin −35.5% −6.9% 4.8% 11.2% 6.6% 4.3% 5.4% 6.3% 5.7%
Free-cash-flow margin −7.1% −0.7% 11.2% 13.8% 1.5% 6.8% 9.2% 16.2% 3.5%
Cash flow
Cash from operations 0.5 1.1 2.1 2.7 0.9 1.8 2.1 3.4 1.2
Capital spending 1.5 1.2 0.5 0.6 0.6 0.6 0.6 0.6 0.6
Free cash flow −1.0 −0.1 1.6 2.2 0.3 1.2 1.5 2.8 0.6
Stock-based pay 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 —
Free cash flow after stock pay −1.1 −0.2 1.5 2.1 0.3 1.1 1.5 2.8 —
Balance sheet
Cash 2.3 1.8 3.5 4.5 3.2 2.6 3.1 4.5 2.4
Total debt 7.9 0.1 1.1 1.1 1.3 2.5 2.7 2.6 4.9
Net debt (negative = net cash) 5.7 −1.6 −2.4 −3.3 −1.9 −0.2 −0.4 −1.9 2.5
Diluted shares 749m 750m 751m 742m 725m 712m 696m 681m 675m
Returned to shareholders
Dividends 0.0 −0.2 −0.4 0.4 0.4 0.4 0.5 0.5 0.5
Buybacks 0.0 0.0 0.3 1.0 1.0 0.8 1.0 1.1 1.1
Total returned 0.0 −0.2 −0.1 1.3 1.4 1.2 1.5 1.5 1.5

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

3 of 5 checks passed · June 30, 2026
What it owns · $41.6bn
Short-term assets $16.4bnLonger-term assets $25.3bn
What it owes, and who funded it · $35.9bn
Short-term liabilities $10.8bnShareholders' equity $25.2bn
  • Short-term assets cover short-term liabilities $16.4bn of assets due within a year against $10.8bn of liabilities due within a year.
  • Short-term assets cover long-term liabilities Not assessable from the reported split. Not assessable.
  • More cash than debt $2.4bn of cash against $4.9bn of debt.
  • Debt below 40% of shareholders' equity Debt is 19% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 4% to 19% over five years.
  • A year's operating cash flow covers at least 20% of debt $1.2bn of operating cash flow against $4.9bn of debt.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Corteva, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

FY2026 Q2 TTM
Buybacks (TTM)
$1.1B
Dividends (TTM)
$484M
Returned to shareholders
244%
of free cash flow
Buybacks, last 3 fiscal years
$2.8B
Diluted share count
−1.9%
year over year
Total shareholder yield
19.2%
dividends 6.0% + buybacks 13.1% of market value
Dividend payout ratio
48%
of net income paid out
R&D spending
8.4%
of revenue
Sales & admin spending
20.4%
of revenue
Days sales outstanding
120 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in fertilizers & agricultural chemicals
Last 12 months unless stated CTVA MOS NTR CF ICL SMG Median
Revenue, last 12 months $17.8bn $12.2bn $26.9bn $7.7bn $7.2bn $3.5bn $3.5bn
Revenue growth, last 12 months 3.7% 8.8% 3.5% 20.0% 4.6% 4.6% 3.7%
Revenue growth, 3-year average 0.5% −10.0% — −3.9% — −1.7% −4.2%
Revenue growth, latest quarter −1.2% −6.0% — 17.6% — 1.1% −1.2%
Gross margin 49.5% 11.0% 31.0% 42.5% 30.6% 31.8% 31.0%
Operating margin — −1.4% 13.9% 41.1% 8.1% 11.0% 3.4%
Operating margin, 3-year average — 4.2% 11.9% 32.7% 12.4% 6.8% 6.8%
Net margin 5.7% −5.2% 8.4% 27.1% 3.2% 2.1% 2.1%
Cash from operations / revenue 6.8% 3.6% 14.9% 38.5% 14.8% 10.6% 14.8%
Free-cash-flow margin 3.5% −7.7% 7.4% 24.7% 4.6% 7.6% 7.4%
Free-cash-flow margin, 3-year average 9.2% −1.3% 9.1% 26.0% 7.0% 14.4% 9.1%
Stock pay / revenue 0.5% 0.3% 0.6% 0.6% 0.2% 1.4% 0.6%
Change in share count −1.9% −0.1% −1.6% −8.6% 0.1% 3.2% 0.1%

Median of all 11 companies we cover in fertilizers & agricultural chemicals. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

11 fertilizers & agricultural chemicals companies
Measure Company Peer median Rank
Revenue growth Growth 3.7% 3.7% 6 of 11
Change in growth rate Growth -2.6pp -0.8pp 8 of 11
Gross margin Profitability 49.5% 31.0% 1 of 11
Net margin Profitability 5.7% 2.1% 4 of 11
Free-cash-flow margin Cash generation 3.5% 7.4% 8 of 11
Long-term debt as % of assets Balance sheet 4.0% 21.3% 1 of 11
Change in share count Balance sheet -1.9% 0.1% 2 of 11
Days sales outstanding Balance sheet 120 days 75 days 6 of 7

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue YoY
United States $8.3B ▲ 5.1%
Latin America $3.9B ▲ 4.0%
EMEA $3.1B ▼ 0.4%
Brazil $2.9B ▲ 10.8%
Asia Pacific $1.3B ▼ 0.7%
Canada $755M ▼ 4.9%

These categories overlap or exclude eliminations, so shares aren't shown.

From Corteva, Inc.'s 10-K filed February 12, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$50.3B
Institutions reporting
1,472
Shares held vs prior quarter
▲ 2.6%
Positions opened / closed
114 / 99

Top buyers and sellers, Q2 2026: 627 institutions bought and 623 sold ; the biggest buyer was Capital World Investors (+6.9M shares) and the biggest seller Wells Fargo & Company (−4.9M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $4.6B 53.8M 9.1% ▼ 1.6%
Vanguard Capital Management LLC $3.7B 43.8M 7.4% ▼ 0.6%
Capital World Investors $3.6B 42.9M 7.2% ▲ 19.2%
FMR LLC $3.5B 41.1M 6.9% ▲ 17.4%
State Street Corp $3.2B 38.3M 6.4% ▲ 5.9%
Vanguard Portfolio Management LLC $2.5B 29.8M 5.0% ▼ 0.9%
Franklin Resources Inc $1.9B 22.3M 3.8% ▲ 2.5%
Geode Capital Management, LLC $1.6B 18.9M 3.2% ▲ 0.9%
Aristotle Capital Management, LLC $1.5B 17.8M 3.0% ▼ 5.7%
Harris Associates L P $1.4B 16.3M 2.8% ▼ 1.9%
Northern Trust Corp $1B 12.1M 2.0% ▼ 3.3%
Invesco Ltd. $807M 9.5M 1.6% ▼ 12.3%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Corteva, Inc.'s complete shareholder register. Values are as reported by the filers ; 1 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $636,213 2 trades by 1 insider · 0% under pre-set plans
Net ▼ $636,213 net selling
Insider Date Trade Shares Price Value
Titus Brian See Remarks February 20, 2026 Sell 4,000 $76.53 $306,120
Titus Brian See Remarks February 20, 2026 Sell 4,311 $76.57 $330,093

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 18 trades and filings

In the last 12 months, 1 member of Congress disclosed 0 purchases and 1 sale of Corteva, Inc. shares.

  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (partial), $1,001 - $15,000, traded September 17, 2026, filed October 12, 2026
  • John James(R-MI 10):Sale (full), $1,001 - $15,000, traded September 4, 2024, filed September 6, 2024
  • John James(R-MI 10):Purchase, $1,001 - $15,000, traded November 10, 2023, filed September 2, 2024

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around October 29, 2026 estimated from the company's past filing pattern, not announced

  • July 30, 2026
  • May 5, 2026
  • February 3, 2026
  • November 4, 2025
  • October 1, 2025
  • August 6, 2025

Recent SEC filings

Data status

When each part of this page on Corteva, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Corteva, Inc. in brief

What does Corteva, Inc. do?
Corteva, Inc. is a US-listed company in the fertilizers & agricultural chemicals industry. Its financial year ends in December.
What is Corteva, Inc.'s stock ticker?
Corteva, Inc. trades under the ticker CTVA on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Corteva, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Corteva, Inc. reported revenue of $17.8B, 3.7% higher than a year earlier, according to its SEC filings.
What is Corteva, Inc.'s free cash flow?
Corteva, Inc.'s free-cash-flow margin is 3.5% of revenue over the trailing twelve months, ranking 8 of the 11 fertilizers & agricultural chemicals companies we cover.
Who are Corteva, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Capital Management LLC and Capital World Investors. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Is Corteva, Inc. buying back stock, and does it pay a dividend?
Corteva, Inc. spent $1.1B on share repurchases over the trailing twelve months, and its diluted share count fell 1.9% over the year.
What is Corteva, Inc.'s market cap?
On November 2, 2026, Corteva, Inc.'s market capitalisation was about $8B, with a price-to-earnings ratio of 8.0 and net debt of $2.5B. Market figures come from third-party market data and may be delayed.
Does Corteva, Inc. pay a dividend?
Yes: Corteva, Inc. paid $484M in dividends over the trailing twelve months, a dividend yield of 6.04% and a payout ratio of 48.0%.
How much debt does Corteva, Inc. have?
Corteva, Inc.'s debt-to-equity ratio is 19.4%, from its latest balance sheet (4.3% five years earlier). The financial health section below sets out its other solvency checks.
Who are Corteva, Inc.'s competitors?
In our Fertilizers & Agricultural Chemicals peer group, the companies closest to Corteva, Inc. are The Mosaic Company, Nutrien Ltd., CF Industries, ICL Group Ltd. and Scotts Miracle-gro Co. The side-by-side comparison below sets their revenue, margins and growth against Corteva, Inc.'s.
Are insiders buying or selling Corteva, Inc. stock?
Over the last 12 months, Corteva, Inc.'s directors and officers reported 0 open-market purchases and 2 sales on Form 4. The insider trading page charts every trade.
When is Corteva, Inc.'s next earnings date?
Around November 11, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Corteva, Inc. announces its own schedule.